Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 2327 results found since Jan 2013.

Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
CONCLUSION: The rate of adverse reactions after established vaccinations was roughly comparable to previous studies. Two weeks after vaccination, participants in the SARS-CoV-2 vaccination group reported more local and systemic local reactions than participants in the comparator group. In the further course, however, there were no higher odds of medical consultations in either of the two groups. Thus, altogether, we assume comparable safety.TRIAL REGISTRATION: DRKS-ID DRKS00025881 and DRKS-ID DRKS00025373.PMID:37726711 | DOI:10.1186/s12916-023-03064-6
Source: Herpes - September 19, 2023 Category: Infectious Diseases Authors: Felix Werner Nikoletta Zeschick Thomas K ühlein Philipp Steininger Klaus Überla Isabelle Kaiser Maria Sebasti ão Susann Hueber Lisette Warkentin Source Type: research

Similar herpes zoster incidence across Europe: results from a systematic literature review
Background: Herpes zoster (HZ) is caused by reactivation of the varicella-zoster virus (VZV) and mainly affects individuals aged>=50 years. The forthcoming European launch of a vaccine against HZ (Zostavax(R)) prompts the need for a better understanding of the epidemiology of HZ in Europe. Therefore the aim of this systematic review was to summarize the available data on HZ incidence in Europe and to describe age-specific incidence. Methods: The Medline database of the National Library of Medicine was used to conduct a comprehensive literature search of population-based studies of HZ incidence published between 1960 and 20...
Source: BMC Infectious Diseases - April 10, 2013 Category: Infectious Diseases Authors: Sybil PinchinatAna Cebrián-CuencaHélène BricoutRobert Johnson Source Type: research

Trends and disparity in zoster vaccine uptake in a managed care population.
CONCLUSION: The zoster vaccine coverage is higher in this insured population than previously reported in the US general population, but it remains low. Significant racial/ethnic disparity was observed and worsened even among individuals with relatively equal access to zoster vaccination. PMID: 23928461 [PubMed - as supplied by publisher]
Source: Vaccine - August 5, 2013 Category: Allergy & Immunology Authors: Hechter RC, Tartof SY, Jacobsen SJ, Smith N, Tseng HF Tags: Vaccine Source Type: research

Comment Prevention of varicella: time for two-dose vaccination
Live-attenuated varicella zoster virus (VZV) vaccines have been available for decades, but their potential to reduce disease worldwide has not been fully realised. Few countries have incorporated varicella vaccination into public programmes, even though rapid and large decreases in varicella deaths and admissions have been achieved in the USA and Australia. and Varivax, Merck), field effectiveness has turned out to be lower at 72–81%. has made estimation of cost-effectiveness difficult. This absence of information has been the main reason for countries such as Australia continuing a one-dose programme.
Source: LANCET - April 11, 2014 Category: Journals (General) Authors: Kristine Macartney Tags: Comment Source Type: research

Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
CONCLUSIONS: Recommendations from healthcare providers are valued by patients and can improve vaccination rates. The patient education program increased interest in receiving Zostavax(®) and this interest differed depending on the reason provided for being unvaccinated. PMID: 25171848 [PubMed - as supplied by publisher]
Source: Vaccine - August 26, 2014 Category: Allergy & Immunology Authors: Teeter BS, Garza KB, Stevenson TL, Williamson MA, Zeek ML, Westrick SC Tags: Vaccine Source Type: research

Could depression be the result of a brain infection?
ConclusionThe paper's hypothesis is interesting, but it remains just that – a hypothesis. While it is true that some pathogens, such as the Borna disease virus mentioned in the article, have been linked with neuropsychiatric disorders, there is no proof as yet that bacteria, viruses or parasites could cause major depression. Still, as the old truism goes: "Absence of evidence is not the same as evidence of absence". The lack of evidence could be because nobody has bothered to look for it before.The author concludes that, "It would be worthwhile to conduct large-scale studies of carefully characterised de...
Source: NHS News Feed - November 28, 2014 Category: Consumer Health News Tags: Mental health Source Type: news

Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
CONCLUSIONS: Based on published immunogenicity, efficacy, and safety data, as well as the recent recommendations by the ACIP, HZ/su should be included on both hospital and community pharmacy formularies and recommended to all immunocompetent patients older than 50 years to prevent herpes zoster. PMID: 29457489 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - February 1, 2018 Category: Drugs & Pharmacology Authors: James SF, Chahine EB, Sucher AJ, Hanna C Tags: Ann Pharmacother Source Type: research

Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant.
CONCLUSION: HepB-CpG has been shown to be as immunogenic as Engerix-B; however, long-term safety and persistence of immune memory has yet to be established. PMID: 32988213 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - September 27, 2020 Category: Drugs & Pharmacology Authors: Champion CR Tags: Ann Pharmacother Source Type: research

Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis
CONCLUSIONS: There is little research focusing specifically on healthcare workers' perceptions and experiences of communication with older adults about vaccination. The studies we identified suggest that healthcare workers differed among themselves in their perceptions about the aim of this communication and about the role of older adults in vaccine decisions. Based on these findings and the other findings in our review, we have developed a set of questions or prompts that may help health system planners or programme managers when planning or implementing strategies for vaccination communication between healthcare workers ...
Source: Cochrane Database of Systematic Reviews - July 20, 2021 Category: General Medicine Authors: Claire Glenton Benedicte Carlsen Simon Lewin Manuela Dominique Wennekes Brita Askeland Winje Renske Eilers VITAL consortium Source Type: research

Pityriasis rosea, pityriasis rosea-like eruptions and herpes zoster in the setting of covid-19 and covid-19 vaccination
Clin Dermatol. 2022 Jan 27:S0738-081X(22)00002-5. doi: 10.1016/j.clindermatol.2022.01.002. Online ahead of print.ABSTRACTPityriasis rosea (PR), pityriasis rosea like eruptions (PR-LEs) and herpes zoster (HZ) have been frequently reported during COVID-19 or following COVID-19 vaccination. PR is a self-limiting exanthematous disease and HZ a treatable condition, therefore their occurrence does not require discontinuation of the vaccination schedule. PR-LE is a hypersensitivity reaction and, therefore, less predictable in its course. In case of booster dose, the clinical manifestation may not recur, may be different from PR-L...
Source: Herpes - January 30, 2022 Category: Infectious Diseases Authors: Francesco Drago Francesco Broccolo Giulia Ciccarese Source Type: research

Knowledge and Attitudes Concerning Herpes Zoster among People with COPD: An Interventional Survey Study
Vaccines (Basel). 2022 Mar 10;10(3):420. doi: 10.3390/vaccines10030420.ABSTRACTHerpes zoster (HZ) is common in older adults with conditions such as chronic obstructive pulmonary disease (COPD). Effective prevention is available through vaccination, but HZ vaccine uptake remains incomplete. Using an online survey of people with self-reported COPD, ShiPPS assessed HZ risk awareness, HZ vaccine use and barriers, and the impact of an HZ educational video on vaccine intent. USA members of the COPD Foundation's Patient-Powered Research Network aged >50 years were surveyed in fall 2020. The responses were analyzed using de...
Source: Herpes - March 26, 2022 Category: Infectious Diseases Authors: Barbara P Yawn Debora D Merrill Sergio Martinez Elisabeth Callen Janice Cotton Dennis Williams Natalia Y Loskutova Source Type: research

Neuro-Ophthalmological Complications of the COVID-19 Vaccines: A Systematic Review
CONCLUSION: Since the implementation of the COVID-19 vaccination campaign in the past year, several post-COVID-vaccination neuro-ophthalmological complications have been described. However, considering the number of individuals that have been exposed to the vaccines, the risk seems very low, and the clinical outcome in most cases is favorable. Therefore, on a population level, the benefits of the vaccines far outweigh the risk of neuro-ophthalmological complications.PMID:35427282 | DOI:10.1097/WNO.0000000000001537
Source: Herpes - April 15, 2022 Category: Infectious Diseases Authors: Itay Lotan Melissa Lydston Michael Levy Source Type: research

Strategies to improve vaccination rates in people who are homeless: A systematic review
Vaccine. 2022 Apr 25:S0264-410X(22)00436-4. doi: 10.1016/j.vaccine.2022.04.022. Online ahead of print.ABSTRACTPeople who are homeless experience higher rates of vaccine-preventable disease, including COVID-19, than the general population, and poorer associated health outcomes. However, delivering vaccinations to people who are homeless is complex, and there is a lack of evidence to inform practice in this area. The aim of this systematic review is to: (a) identify, (b) analyse the characteristics of, and (c) evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless. Literature was retriev...
Source: Vaccine - April 28, 2022 Category: Allergy & Immunology Authors: Laura K McCosker Asmaa El-Heneidy Holly Seale Robert S Ware Martin J Downes Source Type: research